LSE:NIOX (NIOX Group Plc)
About NIOX
Niox Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis and management of asthma. It offers NIOX VERO, a non-invasive point-of-care system that provides fractional exhaled nitric oxide (FeNO) measurements. The company was founded by Steven Harris and Charles Stuart Webb Swingland on May 19, 2006 and is headquartered in Oxford, the United Kingdom.
NIOX Group Plc (LSE: NIOX) Latest News
Investing Articles
Stock alert! Why I’m still shunning this former Neil Woodford favourite
Investing Articles
Could the Hurricane Energy share price be the bargain of the year?
Investing Articles
National Grid is a FTSE 100 dividend stock I’d buy with £1,000 today
Investing Articles
Should you buy Neil Woodford stock Circassia Pharmaceuticals after today’s price rise?
Investing Articles
2 Neil Woodford stocks I wouldn’t touch with a bargepole
Investing Articles
2 future growth stocks I’d buy today
Investing Articles
2 turnaround stocks that could make you rich
Investing Articles
2 recovering growth stocks to help you achieve financial independence
Investing Articles
3 stocks you can buy today for up to 70% less than Neil Woodford paid!
Investing Articles
Has Brexit created the perfect opportunity to buy Woodford Patient Capital Trust plc?
Investing Articles
Can this week’s big fallers bounce back? Circassia Pharmaceuticals plc (-59%), Stadium Group plc (-27%) & Photo-Me International plc (-11%)
Investing Articles
Why are Circassia Pharmaceuticals plc, Royal Bank of Scotland Group plc and McColl’s Retail Group plc among today’s major movers?
1❯